Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Cardiotoxicity 2Triple Negative Breast Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Long QT Syndrome 1Leukemia, Myeloid, Acute 1Heart Failure 1Colonic Neoplasms 1Brugada Syndrome 1Breast Neoplasms 1Arrhythmias, Cardiac 1

Interventions

Exercise 8salicylhydroxamic acid 2High-Intensity Interval Training 2Electrocardiography 2Echocardiography 2sacubitril and valsartan sodium hydrate drug combination 1mitoquinone 1epicatechin gallate 1candesartan 1Therapeutics 1Surveys and Questionnaires 1Secondary Prevention 1Restraint, Physical 1Rehabilitation 1Proton Therapy 1Proteins 1Palliative Care 1Methods 1Medical History Taking 1Magnetic Resonance Spectroscopy 1Laser-Doppler Flowmetry 1Ivabradine 1Heart Rate 1Heart Function Tests 1Exercise Test 1Echocardiography, Stress 1Diagnostic Imaging 1Cardiac Rehabilitation 1Blood Pressure 1Blood Cell Count 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Cardiotoxicity × Electrocardiography × Clear all
NCT05703126 2024-11-05

Clinical and Diagnostic Significance of Endothelial Dysfunction and Myocardial Contractility in Patients With AML

Samara State Medical University

Phase NA Recruiting
100 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute, Cardiotoxicity

NCT05676606 2024-03-08

Cardiotoxicity Monitoring With Single-lead Electrocardiogram

I.M. Sechenov First Moscow State Medical University

Phase NA Completed
120 enrolled

Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡